Literature DB >> 31655156

TDP-43 regulates transcription at protein-coding genes and Alu retrotransposons.

Andrés A Morera1, Nasiha S Ahmed1, Jacob C Schwartz2.   

Abstract

The 43-kDa transactive response DNA-binding protein (TDP-43) is an example of an RNA-binding protein that regulates RNA metabolism at multiple levels from transcription and splicing to translation. Its role in post-transcriptional RNA processing has been a primary focus of recent research, but its role in regulating transcription has been studied for only a few human genes. We characterized the effects of TDP-43 on transcription genome-wide and found that TDP-43 broadly affects transcription of protein-coding and noncoding RNA genes. Among protein-coding genes, the effects of TDP-43 were greatest for genes <30 thousand base pairs in length. Surprisingly, we found that the loss of TDP-43 resulted in increased evidence for transcription activity near repetitive Alu elements found within expressed genes. The highest densities of affected Alu elements were found in the shorter genes, whose transcription was most affected by TDP-43. Thus, in addition to its role in post-transcriptional RNA processing, TDP-43 plays a critical role in maintaining the transcriptional stability of protein-coding genes and transposable DNA elements.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alu SINE; GRO-seq; Retrotransposon; TARDBP; TDP-43; Transcription

Mesh:

Substances:

Year:  2019        PMID: 31655156      PMCID: PMC6899060          DOI: 10.1016/j.bbagrm.2019.194434

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   6.304


  68 in total

1.  TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.

Authors:  Jonathan P Ling; Olga Pletnikova; Juan C Troncoso; Philip C Wong
Journal:  Science       Date:  2015-08-07       Impact factor: 47.728

Review 2.  Understanding the role of TDP-43 and FUS/TLS in ALS and beyond.

Authors:  Sandrine Da Cruz; Don W Cleveland
Journal:  Curr Opin Neurobiol       Date:  2011-08-02       Impact factor: 6.627

Review 3.  Nuclear function of Alus.

Authors:  Chen Wang; Sui Huang
Journal:  Nucleus       Date:  2014-02-04       Impact factor: 4.197

Review 4.  Alu elements: know the SINEs.

Authors:  Prescott Deininger
Journal:  Genome Biol       Date:  2011-12-28       Impact factor: 13.583

5.  Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models.

Authors:  Arnaud Tauffenberger; Babykumari P Chitramuthu; Andrew Bateman; Hugh P J Bennett; J Alex Parker
Journal:  Hum Mol Genet       Date:  2012-11-19       Impact factor: 6.150

6.  Structural insights into transcriptional repression by noncoding RNAs that bind to human Pol II.

Authors:  Susanne A Kassube; Jie Fang; Patricia Grob; Petro Yakovchuk; James A Goodrich; Eva Nogales
Journal:  J Mol Biol       Date:  2012-09-04       Impact factor: 5.469

7.  Intrinsically disordered RGG/RG domains mediate degenerate specificity in RNA binding.

Authors:  Bagdeser A Ozdilek; Valery F Thompson; Nasiha S Ahmed; Connor I White; Robert T Batey; Jacob C Schwartz
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

8.  Tdp-43 cryptic exons are highly variable between cell types.

Authors:  Yun Ha Jeong; Jonathan P Ling; Sophie Z Lin; Aneesh N Donde; Kerstin E Braunstein; Elisa Majounie; Bryan J Traynor; Katherine D LaClair; Thomas E Lloyd; Philip C Wong
Journal:  Mol Neurodegener       Date:  2017-02-02       Impact factor: 14.195

9.  Transposable elements in TDP-43-mediated neurodegenerative disorders.

Authors:  Wanhe Li; Ying Jin; Lisa Prazak; Molly Hammell; Josh Dubnau
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

10.  The Caenorhabditis elegans Ortholog of TDP-43 Regulates the Chromatin Localization of the Heterochromatin Protein 1 Homolog HPL-2.

Authors:  Tassa K Saldi; Patrick Gonzales; Alfonso Garrido-Lecca; Vishantie Dostal; Christine M Roberts; Leonard Petrucelli; Christopher D Link
Journal:  Mol Cell Biol       Date:  2018-07-16       Impact factor: 4.272

View more
  6 in total

1.  Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein.

Authors:  Jorge A Trejo-Lopez; Zachary A Sorrentino; Cara J Riffe; Grace M Lloyd; Sydney A Labuzan; Dennis W Dickson; Anthony T Yachnis; Stefan Prokop; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-09-06       Impact factor: 3.046

2.  A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALS.

Authors:  Marc Shenouda; Shangxi Xiao; Laura MacNair; Agnes Lau; Janice Robertson
Journal:  Front Neurosci       Date:  2022-06-21       Impact factor: 5.152

3.  TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6.

Authors:  Erik M Lehmkuhl; Suvithanandhini Loganathan; Eric Alsop; Alexander D Blythe; Tina Kovalik; Nicholas P Mortimore; Dianne Barrameda; Chuol Kueth; Randall J Eck; Bhavani B Siddegowda; Archi Joardar; Hannah Ball; Maria E Macias; Robert Bowser; Kendall Van Keuren-Jensen; Daniela C Zarnescu
Journal:  Acta Neuropathol Commun       Date:  2021-03-24       Impact factor: 7.801

Review 4.  Factors Regulating the Activity of LINE1 Retrotransposons.

Authors:  Maria Sergeevna Protasova; Tatiana Vladimirovna Andreeva; Evgeny Ivanovich Rogaev
Journal:  Genes (Basel)       Date:  2021-09-30       Impact factor: 4.096

5.  Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells.

Authors:  Yoshiaki Yamanaka; Tamami Miyagi; Yuichiro Harada; Masahiko Kuroda; Kohsuke Kanekura
Journal:  Lab Invest       Date:  2021-06-15       Impact factor: 5.502

6.  Retrovirus reactivation in CHMP2BIntron5 models of frontotemporal dementia.

Authors:  Laura Fort-Aznar; Chris Ugbode; Sean T Sweeney
Journal:  Hum Mol Genet       Date:  2020-09-29       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.